Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF.
deFilippi CR, Shah P, Shah SJ, Alemayehu W, Lam CSP, Butler J, Roessig L, O'Connor CM, Westerhout CM, Armstrong PW; VITALITY-HFpEF Study Group. deFilippi CR, et al. Among authors: roessig l. Circ Heart Fail. 2024 Sep;17(9):e011792. doi: 10.1161/CIRCHEARTFAILURE.124.011792. Epub 2024 Aug 29. Circ Heart Fail. 2024. PMID: 39206547 Clinical Trial.
Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial.
Tromp J, Lam CSP, Alemayehu W, de Filippi CR, Melenovský V, Sliwa K, Lopatin Y, Arango JL, Bahit MC, Roessig L, O'Connor CM, Shah P, Westerhout CM, Voors AA, Pieske B, Armstrong PW; VICTORIA Study Group. Tromp J, et al. Among authors: roessig l. Eur J Heart Fail. 2024 Oct;26(10):2231-2239. doi: 10.1002/ejhf.3397. Epub 2024 Jul 30. Eur J Heart Fail. 2024. PMID: 39078607 Clinical Trial.
Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial.
Khan MS, Butler J, Young R, Lewis BS, Escobedo J, Refsgaard J, Reyes E, Roessig L, Blaustein RO, Lam CSP, Voors AA, Ponikowski P, Anstrom KJ, Armstrong PW; VICTORIA Study Group. Khan MS, et al. Among authors: roessig l. JACC Heart Fail. 2024 Oct;12(10):1750-1759. doi: 10.1016/j.jchf.2024.05.007. Epub 2024 Jun 26. JACC Heart Fail. 2024. PMID: 38934967 Clinical Trial.
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat.
Fritsch A, Meyer M, Blaustein RO, Trujillo ME, Kauh E, Roessig L, Boettcher M, Becker C. Fritsch A, et al. Among authors: roessig l. Clin Pharmacokinet. 2024 Jun;63(6):751-771. doi: 10.1007/s40262-024-01384-1. Epub 2024 Jun 25. Clin Pharmacokinet. 2024. PMID: 38916717 Free PMC article. Review.
Framework of the strengths and challenges of clinically integrated trials: An expert panel report.
Peters AE, Jones WS, Anderson B, Bramante CT, Broedl U, Hornik CP, Kehoe L, Knowlton KU, Krofah E, Landray M, Locke T, Patel MR, Psotka M, Rockhold FW, Roessig L, Rothman RL, Schofield L, Stockbridge N, Trontell A, Curtis LH, Tenaerts P, Hernandez AF. Peters AE, et al. Among authors: roessig l. Am Heart J. 2024 Sep;275:62-73. doi: 10.1016/j.ahj.2024.05.009. Epub 2024 May 23. Am Heart J. 2024. PMID: 38795793 Free PMC article. Review.
Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction.
Mentz RJ, Stebbins A, Butler J, Chiang CE, Ezekowitz JA, Hernandez AF, Hilkert R, Lam CSP, McDonald K, O'Connor CM, Pieske B, Ponikowski P, Roessig L, Sweitzer NK, Voors AA, Anstrom KJ, Armstrong PW; VICTORIA Study Group. Mentz RJ, et al. Among authors: roessig l. JACC Heart Fail. 2024 May;12(5):839-846. doi: 10.1016/j.jchf.2023.12.005. Epub 2024 Feb 14. JACC Heart Fail. 2024. PMID: 38363272 Clinical Trial.
Drug development for major chronic health conditions-aligning with growing public health needs: Proceedings from a multistakeholder think tank.
Krychtiuk KA, Andersson TL, Bodesheim U, Butler J, Curtis LH, Elkind M, Hernandez AF, Hornik C, Lyman GH, Khatri P, Mbagwu M, Murakami M, Nichols G, Roessig L, Young AQ, Schilsky RL, Pagidipati N. Krychtiuk KA, et al. Among authors: roessig l. Am Heart J. 2024 Apr;270:23-43. doi: 10.1016/j.ahj.2024.01.004. Epub 2024 Jan 17. Am Heart J. 2024. PMID: 38242417
Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY-HFpEF trial.
Butler J, Khan MS, Gasior T, Erickson TR, Vlajnic V, Kramer F, Blaustein RO, Goldsbury D, Roessig L, Lam CSP, Anstrom KJ, Armstrong PW; VITALITY Study Group. Butler J, et al. Among authors: roessig l. ESC Heart Fail. 2024 Feb;11(1):293-298. doi: 10.1002/ehf2.14572. Epub 2023 Nov 20. ESC Heart Fail. 2024. PMID: 37985002 Free PMC article. Clinical Trial.
Relationship between baseline electrocardiographic measurements and outcomes in patients with high-risk heart failure: Insights from the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trial.
Yogasundaram H, Zheng Y, Ly E, Ezekowitz J, Ponikowski P, Lam CSP, O'Connor C, Blaustein RO, Roessig L, Temple T, Westerhout CM, Armstrong PW, Sandhu RK; VICTORIA Study Group. Yogasundaram H, et al. Among authors: roessig l. Eur J Heart Fail. 2023 Oct;25(10):1822-1830. doi: 10.1002/ejhf.3021. Epub 2023 Sep 10. Eur J Heart Fail. 2023. PMID: 37655679 Free article. Clinical Trial.
Evolution of NT-proBNP During Prerandomization Screening in VICTORIA: Implications for Clinical Outcomes and Efficacy of Vericiguat.
Armstrong PW, Zheng Y, Lund LH, Butler J, Troughton RW, Emdin M, Lam CSP, Ponikowski P, Blaustein RO, O'Connor CM, Roessig L, Voors AA, Ezekowitz JA, Westerhout CM; VICTORIA Study Group. Armstrong PW, et al. Among authors: roessig l. Circ Heart Fail. 2023 Oct;16(10):e010661. doi: 10.1161/CIRCHEARTFAILURE.123.010661. Epub 2023 Jul 28. Circ Heart Fail. 2023. PMID: 37503602
74 results